Entecavir (ETV) is a drug used as a first-line treatment for chronic hepatitis B (CHB) virus infection because it is a guanosine nucleoside analogue with activity against the hepatitis B …
N Shah, V Ioffe, JC Chang - The Canadian journal of urology, 2022 - ncbi.nlm.nih.gov
Materials and methods: We completed a retrospective comparative analysis of 1703 sequential patients that had a Pbx in 2010 to 2012 (3 years) with 1006 patients biopsied in …
S Mukherjee, D Papadopoulos, JM Norris… - Journal of Clinical …, 2023 - mdpi.com
Currently, there is no clear consensus regarding the role of active surveillance (AS) in the management of intermediate-risk prostate cancer (IRPC) patients. We aim to analyse data …
CY Hsu, CH Yang, MC Tung, HJ Liu, YC Ou - Cancers, 2023 - mdpi.com
Simple Summary Theranostic robot-assisted radical prostatectomy (T-RARP) means adopting RARP as an integration of diagnosis and therapy, and this concept has rarely been …
BA Gartrell, A Phalguni, P Bajko, SD Mundle… - European Urology …, 2024 - Elsevier
Context Treatment decision-making (TDM) for patients with localized (LPC) or locally advanced (LAPC) prostate cancer is complex, and post-treatment decision regret (DR) is …
A Morales, DR Siemens - Urologic Clinics, 2022 - urologic.theclinics.com
In men's health 2 fields share the characteristics of being both controversial and involving several medical disciplines: testosterone deficiency syndrome (TDS) and prostate cancer …
NM Posielski, S Shanmuga, O Ho, J Jiang… - Prostate cancer and …, 2023 - nature.com
Abstract Introduction Racial differences in Health-Related Quality of Life (HRQoL) after treatment of prostate cancer (PCa) are not well studied. We compared treatment patterns …
Active surveillance has been proposed as a therapeutic option in selected intermediate risk patients with biopsy grade group 2 prostate cancer. However, its oncologic safety in this …
C Dariane, F Chierigo, V Ouellet, N Delvoye… - The French Journal of …, 2024 - Elsevier
Introduction Active surveillance (AS) has emerged as a primary management strategy for low-risk prostate cancer (PC) patients. We aimed to assess AS uptake over a 1-year …